Purdue Pharma L.p.

Euro-celtique S.a.

Lino Tavares

Benjamin Oshlack

Curtis Wright

Richard S Sackler

Bruce Reidenberg

Anthony E Carpanzano

Stephen A Howard

Kirti H Valia

Ihor Shevchuk

Mark Alfonso

Geraldine Marcenyac

Mohammed Shameem

Richard Maskiewicz

Lane Gehrlein

Kevin Long

Seth Levy

Ronald Greenbaum

James P Cassidy

Stephan Howard

Lane Gerhlein

Mark A Alfonso

A tansdermal delivery device for effectively treating seasonal allergic rhinitis and chronic idiopathic urticariain in humans is disclosed and methods thereof.

Loratadine transdermal device and methods

A method of effectively treating benign prostatic hypertension in humans is achieved by administering amorphous terazosin via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24 hours, and preferably for about 3 to about 8 days.

Terazosin transdermal device and methods

A method of effectively treating hypertension in humans is achieved by administering felodipine via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24 hours days, and preferably for about 3 to about 8 days.

Felodipine transdermal device and methods

Growing community of inventors

Kinnelon, NJ, United States of America

Lino Tavares